Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ‌trials by the end of 2026, founder and CEO ‌Demis Hassabis said on ...
Near.AI introduces a secure, private, Rust-based version of OpenClaw called IronClaw, Olas prediction agents unleashed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results